Officials Investigate Potentially Deadly Side Effect of Weight-Loss Drugs

Health officials in the UK are launching an investigation into weight loss drugs after hundreds of consumers reported pancreas issues. Many cases of pancreatitis are linked to GLP-1, glucagon-like peptide-1 receptor agonists — and many of those cases have been fatal.

Nearly 400 reports of pancreatitis are from patients using Mounjaro, Wegovy, Ozempic and liraglutide. A quarter of these cases were reported this year alone.

The Medicines and Healthcare products Regulatory Agency’s (MHRA)...